Amazon is betting on the health sector. With great ambitions in this sector, the American giant is embarking on the development of a vaccine against cancer and wishes to become essential, from medical equipment to pharmacy. Selling online isn’t enough for them: Now Amazon wants to be your doctor. Indeed, the tech giants are increasingly … Read more
Posted on Friday, September 23, 2022 Servier, an international pharmaceutical group, and Oncodesign Precision Medicine (OPM), a subsidiary of Oncodesign specializing in precision medicine, announce a collaborative research agreement, called “STarT Pancreas”, for the identification and validation of new therapeutic targets aimed at the development of new treatments for pancreatic ductal adenocarcinoma (PDAC). For a … Read more
60,000 women are affected by breast cancer each year in France. 15 to 20% of these cancers will recur 10 years after the first diagnosis. Can relapse be prevented? How ? Which breast cancers recur the most? Summary Breast cancer affects almost 60,000 women each year in France. Like all cancers, it can recur. “The … Read more
Identification and validation of new therapeutic targets against pancreatic cancer Construction of a common Artificial Intelligence (AI) analytical platform Generation and pooling of clinical and biological data, AI tools and skills in experimental pharmacology Servier can initiate a partnership with OPM in Drug Discovery based on certain targets discovered thanks to this technological approach SURESNES, … Read more
September 05, 2022 Today at 11:35 The new spin-off from the University of Liège is raising 4.5 million euros to continue its cancer treatment research based on the “reading” of tRNA. A group of investors and the Walloon Region have just injected 4.5 million euros into THERAtRAME, a new spin-off from the University of Liège … Read more
30.08.2022 – 08:15 Krebsliga Switzerland Last year, the Swiss Cancer Research Foundation and the Swiss Cancer League invested a total of CHF 22 million in cancer research. Published today, the report “Cancer Research in Switzerland” presents the results of funded research projects and sheds light on the questions currently occupying independent cancer research. The impressive … Read more
Although the description of tumors has made real progress, their three-dimensional organization is still poorly understood. But recently, an interdisciplinary study of the architecture of tissues derived from hepatoblastoma, a malignant liver tumor in children, has shed new light on the mechanisms underlying its pathological growth and resistance to treatment. . An article to be … Read more
Lung cancer, the most common cancer in the world, is targeted by radiotherapy (RT) in nearly half of cases. Planning RT is a manual, resource-intensive process that can take days or even weeks, and even highly trained physicians vary in their determinations of how much tissue to target with radiation. Additionally, the shortage of radiation … Read more
An artificial intelligence algorithm to identify a group of cancer-causing ‘point mutations’ in TP53 – a gene implicated in around half of all cancerous tumors – has been developed for the first time in the world by a group of researchers of the Hadassah University Medical Center in Jerusalem. A point mutation occurs in a … Read more
The medicine of tomorrow can be summed up with 4 Ps: personalized, preventive, predictive and participatory. With the constant progress in artificial intelligence, predictive medicine wants to increase the chances of survival in the event of serious illness. ” Prevention is better than cure “, this could be the slogan of all these companies dedicated … Read more